Akcea Therapeutics (AKCA) Posts Smaller Q2 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Akcea Reports Financial Results and Highlights for Second Quarter 2018
August 6, 2018 4:05 PM EDTTEGSEDI (inotersen) Approved in European Union             $382 million to fund the company through key milestones in 2019
      Conference Call Webcast Monday, August 6, 4:30 p.m. ET at www.akceatx.com
CAMBRIDGE, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis... More
